Profile
Full Name
Seres Therapeutics, Inc.Ticker Symbol
MCRBExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
June 26, 2015Indexes
Not includedEmployees
103Key Details
Price
$0.46(-30.32%)
Market cap
$80.55M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
$0.00(+100.00% YoY)
PE ratio
-
Next earnings date
May 8, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Seres Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 20, 25 Chardan Capital
BuyMar 14, 25 Goldman Sachs
SellNov 14, 24 Canaccord Genuity
BuyNov 13, 24 Chardan Capital
BuyOct 24, 24 JP Morgan
UnderweightSep 13, 24 Canaccord Genuity
BuyAug 14, 24 Chardan Capital
BuyAug 14, 24 Canaccord Genuity
BuyJun 7, 24 Oppenheimer
PerformJun 7, 24 Canaccord Genuity
BuyInstitutional Ownership
- What is the ticker symbol for Seres Therapeutics?
- Does Seres Therapeutics pay dividends?
- What sector is Seres Therapeutics in?
- What industry is Seres Therapeutics in?
- What country is Seres Therapeutics based in?
- When did Seres Therapeutics go public?
- Is Seres Therapeutics in the S&P 500?
- Is Seres Therapeutics in the NASDAQ 100?
- Is Seres Therapeutics in the Dow Jones?
- When was Seres Therapeutics's last earnings report?
- When does Seres Therapeutics report earnings?
- Should I buy Seres Therapeutics stock now?
What is the ticker symbol for Seres Therapeutics?
The ticker symbol for Seres Therapeutics is NASDAQ:MCRB
Does Seres Therapeutics pay dividends?
No, Seres Therapeutics does not pay dividends
What sector is Seres Therapeutics in?
Seres Therapeutics is in the Healthcare sector
What industry is Seres Therapeutics in?
Seres Therapeutics is in the Biotechnology industry
What country is Seres Therapeutics based in?
Seres Therapeutics is headquartered in United States
When did Seres Therapeutics go public?
Seres Therapeutics's initial public offering (IPO) was on June 26, 2015
Is Seres Therapeutics in the S&P 500?
No, Seres Therapeutics is not included in the S&P 500 index
Is Seres Therapeutics in the NASDAQ 100?
No, Seres Therapeutics is not included in the NASDAQ 100 index
Is Seres Therapeutics in the Dow Jones?
No, Seres Therapeutics is not included in the Dow Jones index
When was Seres Therapeutics's last earnings report?
Seres Therapeutics's most recent earnings report was on Mar 13, 2025
When does Seres Therapeutics report earnings?
The next expected earnings date for Seres Therapeutics is May 8, 2025
Should I buy Seres Therapeutics stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions